Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-08-01
1998-05-12
Kight, John
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 245, 435 6, 514 44, C07H 2104
Patent
active
057506698
ABSTRACT:
Therapeutically utilizable oligonucleotides of the formulae I and II have been obtained by introduction of terminal 3'--3' and 5'--5' linkages. These compounds are stable to nucleases and suppress the biological function of nucleic acids.
REFERENCES:
patent: 4123610 (1978-10-01), Summerton et al.
patent: 4711955 (1987-12-01), Ward et al.
patent: 4795700 (1989-01-01), Dervan et al.
patent: 4835263 (1989-05-01), Nguyen et al.
Krieg et al., "CpG Motifs in Bacterial DNA Trigger Direct B-Cell Activation," Nature, 374, 546-549 (6 Apr. 1995).
M. Ratajczak, et al., "In Vivo Treatment of Human Leukemia in a Scid Mouse Model with c-myb Antisense Oligodeoxynucleotides", Dec. 1992, Proc. Natl. Acad. Sci. USA, vol. 89, pp. 11823-11827.
G. Gray, et al., "Antisense DNA Inhibition of Tumor Growth Induced by c-Ha-ras Oncogene in Nude Mice", Feb. 1993, Cancer Research, pp. 577-580.
Osen-Sand, et al., "Inhibition of Axonal Growth by SNAP-25 Antisense Oligonucleotides in vitro and in vivo", Nature, Jul. 1993, vol. 364, pp. 445-448.
Higgins, et al., "Antisense Inhibition of the p65 Subunit of NF-kB Blocks Tumorigenicity and Causes Tumor Regression", Proc. Natl. Acad. Sci. USA, Nov. 1993, vol. 90, pp. 9901-9905.
Dean, et al., "Inhibition of Protein Kinase C-.alpha. Expression in Human A549 Cells by Antisense Oligonucleotides Inhibits Induction of Intercellular Adhesion Molecule 1 (ICAM-1) mRNA by Phorbol Esters", Journ. of Biological Chemistry, Jun. 1994, vol. 269, No. 23, pp. 16416-16424.
Shi, et al., "Transcatheter Delivery of c-myc Antisense Oligomers Reduces Neointimal Formation in a Porcine Model of Coronary Artery Balloon Injury", Aug. 1994, Basic Science Reports, vol. 90, No. 2, pp. 944-951.
Dean, et al., "Inhibition of Protein Kinase C-.alpha. Expression in Mice After Systemic Administration of Phosphorothioate Antisense Oligodeoxynucleotides", Nov. 1994, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 11762-11766.
Gillardon, et al., "Expression of C-Fos and C-Jun in the Cornea, Lens, and Retina After Ultraviolet Irradiation of the Rat Eye and Effects of Topical Antisense Oligodeoxynucleotides", British Journ. of Ophthalmology, 1995, vol. 79, pp. 277-281.
Gillardon, et al., "Inhibition of C-Fos Expression in the UV-irradiated Epidermis by Topical Application of Antisense Oligodeoxynucleotides Suppresses Activation of Proliferating Cell Nuclear Antigen", Carcinogenesis, 1995, vol. 16, No. 8, pp. 1853-1856.
Field, et al., "Antisense Oligonucleotides: Rational Drug Design for Genetic Pharmacology", Exp. Opin. Invest. Drugs, 1995, vol. 4, No. 9, pp. 799-821.
Skutella, et al., "Antisense Oligodeoxynucleotides for In Vivo Targeting of Corticotropin-Releasing Hormone mRNA: Comparison of Phosphorothioate and 3'-Inverted Probe Performance," Horm. metab. Res., vol. 26, 1994, pp. 460-464.
Gillardon, et al., "Activation of c-Fos contributes to amyloid.beta.-peptide-induced neurotoxicity," Brain Research, 1996, vol. 706, pp. 169-172.
Knorre et al., "Oligonucleotides Linked to Reactive Groups," Ch. 8 in Oligonucleotides-Inhibitors of Gene Expression, Cohen (ed.), CRC Press, Boca Raton, FL, 1989, pp. 173-196.
Helene et al., "Control of Gene Expression by Oligonucleotides Covalently Linked to Intercalating Agents and Nucleic-Acid Cleaving Reagents," Ch. 7 in Oligonucleotides-Inhibitors of Gene Expression, Cohen (ed.), CRC Press, Boca Raton, FL, 1989, pp. 137-172.
Fran.cedilla.ois et al., "Periodic Cleavage of Poly(dA) by Oligothymidylates Covalently Linked to the 1,10-Phenanthroline-Copper Complex," Biochemistry, 27(7), 2272-2276 (1988).
Praseuth et al., "Sequence-Targeted Photosensitized Reactions in Nucleic Acids by Olig-.alpha.-deoxynucleotides and Oligo-.beta.-deoxynucleotides Covalently Linked to Proflavin," Biochemistry, 27(8), 3031-3038 (1988).
Doan et al., "Sequence-Targeted Chemical Modification of Nucleic Acids by Complementary Oligonucleotides Covalently Linked to Porphyrins," Nucleic Acids Research, 15(21), 8643-8659 (1987).
Asseline et al., "Oligodeoxynucleotides Covalently Linked to Intercalating Dyes as Base-Specific Ligands. Influence of Dye Attachment Site," The EMBO Journal, 3(4), 795-800 (1984).
Chu et al., "Nonenzymatic Sequence-Specific Cleavage of Single-Stranded DNA," Proc. Nat. Acad. Sci. USA, 82(Feb), 963-967 (1985).
van der Krol et al., "Modulation of Eukaryotic Gene Expression by Complementary RNA or DNA Sequences," BioTechniques, 6(10), 958-976 (1988).
Thuong et al., "Chemical Synthesis of Natural and Modified Oligodeoxynucleotides," Biochemie, 67, 673-684 (1985).
Zon, "Pharmaceutical Considerations," Ch. 11 in in Oligonucleotides--Inhibitors of Gene Expression, Cohen (ed.), CRC Press, Boca Raton, FL, 1989, pp. 233-247.
Gura, "Antisense Has Growing Pains--Efforts to Develop Antisense Compounds for Cancer, AIDS, and Other Diseases Have Encountered Some Unexpected Questions About How the Drugs Really Work," Science, 270, 575-577 (1995).
Gutai et al.(I), "Evolutionary Variants of Simarian Virus 40: Nucleotide Sequence of a Conserved SV40 DNA Segment Containing the Origin of Viral DNA Replication as an Inverted Repetition," J. Mol. Biol., 126, 259-274 (1978).
Gutai et al.(II), "Evolutionary Variants of Simarian Virus 40: Cellular DNA Sequences and Sequences at Recombinant Joints of Substituted Variants," J. Mol. Biol., 126, 275-288 (1978).
Fiers, "Complete Nucleotide Sequence of SV 40 DNA," Nature, 273, 113-120 (1978).
Tenen et al., "Binding of Simian Virus 40 Large T Antigen from Virus-infected Monkey cells to Wild-type and Mutant Viral Replication Origins," J. Mol. Biol., 168, 791-808 (1983).
Everett et al., "The Repeated GC-rich Motifs Upstream from the TATA Box are Important Elements of the SV 40 Early Promoter," Nucleic Acids Resrarch, 11(8), 2447-2464 (1983).
Renkawitz et al., "Sequences in the Promoter Region of the Chicken Lysozyme Gene Required for Steriod Regulation and Receptor Binding," Cell, 37, 503-510 (1984).
Subramanian et al., "The Primary Structure of Regions of the SV 40 DNA Encoding Ends of mRNA," in Prog. Nucleic Acid Res. Mol. Biol., vol. 19, Cohn et al. eds., Academic Press, 1976, see pp. 157-164.
Wakamiya et al., "Structure of Simian Virus 40 Recombinants That Contain both Host and Viral DNA Sequences, " J. Biol. Chem., 254(9), 3584-3591 (1979).
Goodchild, "Inhibition of Gene Expression by Oligonucleotides,"in Cohen (ed.), CRC Press, Inc., Boca Raton, FL, 1989, see pp. 53-77.
R. S. Root-Bernstein(I), "AIDS IS More Than HIV: Part I," Genetic Engineering News, Sep. 1, 1992, pp. 4-6.
R. S. Root-Bernstein(II), "AIDS IS More Than HIV: Part II," Genetic Engineering News, Sep. 15, 1992, pp. 4-5.
Hood et al., Immunology, 2nd Ed., Bemjamin/Cummings Publishing Co., Menlo Park, CA, 1984, p. 501.
Offensperger et al., "In vivo Inhibition of Duck Hepatitis B Virus Replication and Gene Expression by Phosphorothioate Modified Antisense Oligodeoxynucleotides," EMBO Journal, 12(3), 1257-1262 (1993).
Wahlestedt et al., "Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides," Science, 259, 528-531(1993).
Seliger et al., "Oligonucleotide Analogs with Dialkyl Silyl Internucleotide Linkages," Nucleoside & Nucleotides, 6(1-2), 483-484 (1987).
Sonveaux, "The Organic Chemistry Underlying DNA Synthesis," Bioorganic Chemistry, 14, 274-325 (1986).
Caruthers, "Synthesis of Oligonucleotides and Oligonucleotide Analogues," J. S. Cohen (ed.), CRC Press, Inc., Boca Raton, FL, 1989, see pp. 7-24.
Cohen, "Introduction: Strategies and Realities," Introduction in Cohen (ed.), CRC Press, Inc., Boca Raton, FL, 1989, see pp. 1-6.
Stein et al., "Phosphorothioate Oligodeoxynucleotide Analogues," Ch. 5 in Cohen (ed.), CRC Press, Inc., Boca Raton, FL, 1989, see pp. 97-117.
Miller, "Non-ionic Antisense Oligonucleotides," Ch. 4 in Cohen (ed.), CRC Press, Inc., Boca Raton, FL, 1989, see pp. 79-95.
Rayner et al., .alpha.-Oligodeoxynucleotide Analgoues, Ch. 6 in Cohen (ed.), CRC Press, Inc., Boca Raton, FL, 1989, see pp. 119-136.
Zamecnik et al., "Inhibition of Rous Sarcoma Virus Replication and Cell Transformation by a Specific Oligodeoxynucleotide," Proc. Nat. Acad. Sci. USA, 7
Frohlich Anja
Montenarh Matthias
Ramalho-Ortigao Jose Flavio
Rosch Hannelore
Seliger Hartmut
Crane L. Eric
Hoechst Aktiengesellschaft
Kight John
LandOfFree
Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-980124